Lung Disease Chronic
7
1
1
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (7)
Exercise Performance on Ambient Air vs. Low-Flow Oxygen Therapy With Chronic Lung Diseases
Powered Assist Hip Exoskeleton to Improve Ambulation in Severe Lung Disease
RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
Project to Improve Communication About Serious Illness - Pilot Study
Severe Lung Disease in Childhood
Postural Drainage With and Without Aerobic Training on Chronic Suppurative Lung Disease
Powered Assist to Improve Ambulation in Severe Lung Disease